MARKET

NVO

NVO

Novo-Nordisk A/S
NYSE
37.91
-0.40
-1.04%
After Hours: 37.96 +0.05 +0.13% 17:50 09/30 EDT
OPEN
38.05
PREV CLOSE
38.31
HIGH
38.77
LOW
37.89
VOLUME
21.39M
TURNOVER
--
52 WEEK HIGH
61.21
52 WEEK LOW
34.20
MARKET CAP
167.71B
P/E (TTM)
9.48
1D
5D
1M
3M
1Y
5Y
1D
The Next Frontier for Obesity Drugs Isn't How Much Weight You Lose, but What Kind
The Wall Street Journal · 3h ago
Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buy
The Motley Fool · 4h ago
FDA launches recruitment drive to add members to advisory panels
Seeking Alpha · 6h ago
Moderately bullish activity in Novo Nordisk with shares down 1.06%
TipRanks · 6h ago
Lexicon Pharmaceuticals: Upgrading On Sotagliflozin HCM Data In Q1 '27 And More
Seeking Alpha · 9h ago
Novo Nordisk Says Next-Gen Obesity Drug Reduces Food Noise, Drives Weight Loss
Benzinga · 10h ago
Novo Nordisk Opens a New Front in Cardiometabolic Care With Early-Stage Anti-Inflammatory Study
TipRanks · 11h ago
Novo Nordisk Tests Cagrisema Switch Strategy to Strengthen Its Diabetes Franchise
TipRanks · 11h ago
More
About NVO
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Webull offers Novo Nordisk A/S (ADR) stock information, including NYSE: NVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVO stock methods without spending real money on the virtual paper trading platform.